非酒精性脂肪性肝病 - Suppr

Suppr

超能文献

Nonalcoholic fatty liver disease.

作者信息

Clark Jeanne M, Brancati Frederick L, Diehl Anna Mae

机构信息

Department of Medicine, The Johns Hopkins University, 720 Rutland Street, Baltimore, MD 21205, USA.

出版信息

Gastroenterology. 2002 May;122(6):1649-57. doi: 10.1053/gast.2002.33573.

DOI:10.1053/gast.2002.33573

PMID:12016429

Abstract

摘要

相似文献

Nonalcoholic fatty liver disease.

Gastroenterology. 2002 May;122(6):1649-57. doi: 10.1053/gast.2002.33573.

AGA technical review on nonalcoholic fatty liver disease.

Gastroenterology. 2002 Nov;123(5):1705-25. doi: 10.1053/gast.2002.36572.

Nonalcoholic fatty liver disease.

N Engl J Med. 2002 Apr 18;346(16):1221-31. doi: 10.1056/NEJMra011775.

Nonalcoholic fatty liver disease: is all the fat bad?

Intern Med J. 2004 Apr;34(4):187-91. doi: 10.1111/j.1444-0903.2004.00574.x.

Nonalcoholic fatty liver disease in pediatric patients.

JPEN J Parenter Enteral Nutr. 2012 Jan;36(1 Suppl):43S-8S. doi: 10.1177/0148607111421610.

Nonalcoholic fatty liver disease.

Am Fam Physician. 2013 Jul 1;88(1):Online.

Approach to the diagnosis and treatment of nonalcoholic fatty liver disease.

Clin Liver Dis. 2005 Nov;9(4):617-34, vi. doi: 10.1016/j.cld.2005.07.002.

Nonalcoholic fatty liver disease.

CMAJ. 2005 Mar 29;172(7):899-905. doi: 10.1503/cmaj.045232.

Nonalcoholic fatty liver disease of obesity.

Obes Surg. 2006 Nov;16(11):1412-9. doi: 10.1381/096089206778870012.

[Current knowledge of nonalcoholic steatohepatitis].

Med Clin (Barc). 2003 Jun 21;121(3):102-8. doi: 10.1016/s0025-7753(03)73870-6.

引用本文的文献

Sex differences in metabolic dysfunction-associated steatotic liver disease: a narrative review.

Ewha Med J. 2024 Apr;47(2):e17. doi: 10.12771/emj.2024.e17. Epub 2024 Apr 30.

Free fatty acid-induced miR-22 inhibits gluconeogenesis via SIRT-1-mediated PGC-1α expression in nonalcoholic fatty liver disease.

ILIVER. 2023 Feb 7;2(1):1-9. doi: 10.1016/j.iliver.2023.01.002. eCollection 2023 Mar.

Molecular Mechanisms, Endurance Athlete, and Synergistic Therapeutic Effects of Marine-Derived Antioxidant Astaxanthin Supplementation and Exercise in Cancer, Metabolic Diseases, and Healthy Individuals.

Food Sci Nutr. 2025 Jun 27;13(7):e70470. doi: 10.1002/fsn3.70470. eCollection 2025 Jul.

Loss of ovarian function prevents exercise-induced activation of hepatic mitophagic flux.

Am J Physiol Endocrinol Metab. 2025 Jun 1;328(6):E869-E884. doi: 10.1152/ajpendo.00107.2025. Epub 2025 Apr 28.

Are alterations needed in Silybum marianum (Silymarin) administration practices? A novel outlook and meta-analysis on randomized trials targeting liver injury.

BMC Complement Med Ther. 2025 Apr 12;25(1):134. doi: 10.1186/s12906-025-04886-y.

Expression Analysis of Circulating miR-21, miR-34a and miR-122 and Redox Status Markers in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients with and Without Type 2 Diabetes.

Int J Mol Sci. 2025 Mar 7;26(6):2392. doi: 10.3390/ijms26062392.

Hepatic Satellite Cell Activation and Alteration of Vitamin A Status Are Relevant to the Aggravation of Retinopathy by T2DM.

Invest Ophthalmol Vis Sci. 2025 Feb 3;66(2):7. doi: 10.1167/iovs.66.2.7.

Quantitative contrast-enhanced ultrasonography in the diagnosis and grading of hepatic steatosis in brain-dead donors.

Quant Imaging Med Surg. 2025 Jan 2;15(1):326-338. doi: 10.21037/qims-24-1004. Epub 2024 Dec 16.

Hormone replacement therapy for steatotic liver management after surgical menopause.

Clin J Gastroenterol. 2025 Apr;18(2):352-356. doi: 10.1007/s12328-024-02090-y. Epub 2025 Jan 6.

Sex Hormone: A Potential Target at Treating Female Metabolic Dysfunction-Associated Steatotic Liver Disease?

J Clin Exp Hepatol. 2025 Mar-Apr;15(2):102459. doi: 10.1016/j.jceh.2024.102459. Epub 2024 Nov 19.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Nonalcoholic fatty liver disease.

作者信息

Clark Jeanne M, Brancati Frederick L, Diehl Anna Mae

机构信息

Department of Medicine, The Johns Hopkins University, 720 Rutland Street, Baltimore, MD 21205, USA.

出版信息

Gastroenterology. 2002 May;122(6):1649-57. doi: 10.1053/gast.2002.33573.

DOI:10.1053/gast.2002.33573

PMID:12016429

Abstract

摘要

相似文献

Nonalcoholic fatty liver disease.

Gastroenterology. 2002 May;122(6):1649-57. doi: 10.1053/gast.2002.33573.

AGA technical review on nonalcoholic fatty liver disease.

Gastroenterology. 2002 Nov;123(5):1705-25. doi: 10.1053/gast.2002.36572.

Nonalcoholic fatty liver disease.

N Engl J Med. 2002 Apr 18;346(16):1221-31. doi: 10.1056/NEJMra011775.

Nonalcoholic fatty liver disease: is all the fat bad?

Intern Med J. 2004 Apr;34(4):187-91. doi: 10.1111/j.1444-0903.2004.00574.x.

Nonalcoholic fatty liver disease in pediatric patients.

JPEN J Parenter Enteral Nutr. 2012 Jan;36(1 Suppl):43S-8S. doi: 10.1177/0148607111421610.

Nonalcoholic fatty liver disease.

Am Fam Physician. 2013 Jul 1;88(1):Online.

Approach to the diagnosis and treatment of nonalcoholic fatty liver disease.

Clin Liver Dis. 2005 Nov;9(4):617-34, vi. doi: 10.1016/j.cld.2005.07.002.

Nonalcoholic fatty liver disease.

CMAJ. 2005 Mar 29;172(7):899-905. doi: 10.1503/cmaj.045232.

Nonalcoholic fatty liver disease of obesity.

Obes Surg. 2006 Nov;16(11):1412-9. doi: 10.1381/096089206778870012.

[Current knowledge of nonalcoholic steatohepatitis].

Med Clin (Barc). 2003 Jun 21;121(3):102-8. doi: 10.1016/s0025-7753(03)73870-6.

引用本文的文献

Sex differences in metabolic dysfunction-associated steatotic liver disease: a narrative review.

Ewha Med J. 2024 Apr;47(2):e17. doi: 10.12771/emj.2024.e17. Epub 2024 Apr 30.

Free fatty acid-induced miR-22 inhibits gluconeogenesis via SIRT-1-mediated PGC-1α expression in nonalcoholic fatty liver disease.

ILIVER. 2023 Feb 7;2(1):1-9. doi: 10.1016/j.iliver.2023.01.002. eCollection 2023 Mar.

Food Sci Nutr. 2025 Jun 27;13(7):e70470. doi: 10.1002/fsn3.70470. eCollection 2025 Jul.

Loss of ovarian function prevents exercise-induced activation of hepatic mitophagic flux.

Am J Physiol Endocrinol Metab. 2025 Jun 1;328(6):E869-E884. doi: 10.1152/ajpendo.00107.2025. Epub 2025 Apr 28.

Are alterations needed in Silybum marianum (Silymarin) administration practices? A novel outlook and meta-analysis on randomized trials targeting liver injury.

BMC Complement Med Ther. 2025 Apr 12;25(1):134. doi: 10.1186/s12906-025-04886-y.

Expression Analysis of Circulating miR-21, miR-34a and miR-122 and Redox Status Markers in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients with and Without Type 2 Diabetes.

Int J Mol Sci. 2025 Mar 7;26(6):2392. doi: 10.3390/ijms26062392.

Hepatic Satellite Cell Activation and Alteration of Vitamin A Status Are Relevant to the Aggravation of Retinopathy by T2DM.

Invest Ophthalmol Vis Sci. 2025 Feb 3;66(2):7. doi: 10.1167/iovs.66.2.7.

Quantitative contrast-enhanced ultrasonography in the diagnosis and grading of hepatic steatosis in brain-dead donors.

Quant Imaging Med Surg. 2025 Jan 2;15(1):326-338. doi: 10.21037/qims-24-1004. Epub 2024 Dec 16.

Hormone replacement therapy for steatotic liver management after surgical menopause.

Clin J Gastroenterol. 2025 Apr;18(2):352-356. doi: 10.1007/s12328-024-02090-y. Epub 2025 Jan 6.

Sex Hormone: A Potential Target at Treating Female Metabolic Dysfunction-Associated Steatotic Liver Disease?

J Clin Exp Hepatol. 2025 Mar-Apr;15(2):102459. doi: 10.1016/j.jceh.2024.102459. Epub 2024 Nov 19.